Summary
The product Drostanolone Propionate 100 mg/ml, manufactured by Vulkan Pharmaceuticals, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 4KJ81V, was submitted by the manufacturer vulkanpharma@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Drostanolone Propionate, with a concentration of 103.77 mg/ml, exceeding the labeled claim of 100 mg/ml by 3.77%.
The testing process began on 29 October 2024, with the sample received on 5 November 2024, and analysis completed on 13 November 2024. While the results confirm accurate dosing, scrutiny of manufacturer-submitted samples is essential to ensure reliability. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Vulkan Pharmaceuticals
- Product Name: Drostanolone Propionate 100 mg/ml
- Active Ingredient: Drostanolone Propionate
- Batch Number: 4KJ81V
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #52527
- Testing Ordered: 29 October 2024
- Sample Received: 5 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Vulkan Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Vulkan Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 103.77 mg/ml
- Accuracy: 103.77% (3.77% above the label claim)
- Variance: +3.77%
Verification Details
- Verification URL: https://janoshik.com/tests/52527_ZTRHLG9Y32CU
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the accuracy of the tested product but warrants careful evaluation due to its submission by the manufacturer. Manufacturer-submitted samples may not always represent the consistency of products available to consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms that Drostanolone Propionate 100 mg/ml is slightly overdosed, with a measured concentration of 103.77 mg/ml. This result reflects strong quality control for this batch but underscores the importance of additional testing to ensure consistent dosing across the product line. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
